<DOC>
	<DOCNO>NCT01024179</DOCNO>
	<brief_summary>Vulnerable plaque characterize thin fibrous cap large lipid core independent risk factor acute cardiac event . Current clinical data show thin-cap fibroatheroma frequently observe patient ACS SAP . Further OCT study indicate patient ACS significantly high incidence incomplete neointimal coverage malapposition DES implantation SAP . These finding imply initial native lesion characteristic may relate different vessel response ( neointimal coverage malapposition ) stenting . However , little data relationship plaque characteristic vascular response DES stent implantation evaluate OCT . Therefore , study design investigate relationship initial plaque characteristic stent surface coverage late malapposition SES implantation . The investigator use high resolution OCT ass initial culprit plaque morphology subsequent vascular response SES stenting time point post-stenting , 6 month 12 month . IVUS also perform evaluate tissue protrusion , malapposition , vessel remodel time point .</brief_summary>
	<brief_title>Relationship Between Initial Plaque Characteristics Stent Surface Coverage Patterns</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Inclusion Criteria General Inclusion Criteria： 1 . Age:1875Y 2 . Patients stable angina acute coronary syndrome consider suitable coronary revascularization . 3 . Patient legal guardian understands agree comply specify study requirement provide write informed consent . Angiographic Inclusion Criteria： 1 . Significant coronary de novo lesion ( &gt; 70 % visual estimation ) . 2 . Target lesion de novo native coronary artery lesion treat 12 stent . 3 . Reference vessel diameter 2.5 4.0 mm . Exclusion Criteria： General Exclusion Criteria： 1 . STsegment elevation myocardial infarction within 7 day prior index procedure . 2 . Previous CABG . 3 . Life expectancy &lt; 12 month due another medical condition . 4 . Contraindication antiplatelet therapy 5 . Creatinine level 2.0mg/dL ESRD . 6 . Severe hepatic dysfunction ( 3 time normal reference value ) . 7 . Planned surgery procedure ≤ 6 month postindex procedure . 8 . Known allergy stainless steel history hypersensitivity sirolimus structurally related compound . 9 . Female childbearing potential positive pregnancy test within 7 day index procedure , lactating , intend become pregnant 12 month post index procedure . 10 . Patient clinically appropriate OCT evaluation opinion investigator . Angiographic Exclusion Criteria： 1 . Study lesion ostial location ( within 3.0 mm vessel origin ) . 2 . Study lesion involve arterial segment highly tortuous anatomy . 3 . Complex lesion morphology ( aortoostial , bifurcation need two stent technique , leave main , severe thrombus , heavy calcification ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Chronic total occlusion</keyword>
</DOC>